UNSPSC 51111753: Mitoguazone
Commodity
Code facts
- Part of
-
-
51000000
-
51110000
- 51111700
-
51110000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51111753
| NIGP code |
|---|
| 26908 Anti-Infective Agents |
Definition
This classification denotes a s-adenosyl-methionine decarboxylase inhibitor and polyamine inhibitory agent with the molecular formula C5H12N8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OD5Q0L447W, chemically known as 1,1-((methylethanediylidene)dinitrilo)diguanidine but generally known as mitoguazone, which bears US NIH Compound Identifier 5351154. European Medicines Agency schedules Mitoguazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09004MIG.
Read the full definition
The term MITOGUAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules mitoguazone in its Anatomical Therapeutic Chemical (ATC) Classification. MITOGUAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mitoguazone under HS 29252900 and SITC 51482. As of Q4 2014, MITOGUAZONE remains the US FDA Preferred Term for this commodity.
Mitoguazone bears US NLM identifiers UMLS ID C0026251 and NCI Concept Code C661. SMILES: N(=C(\C)/C=N/N=C(/N)N)\N=C(\N)N.
About UNSPSC 51111753
UNSPSC 51111753 Mitoguazone is a Commodity code that classifies pharmaceutical products, though recent state and local procurement activity under this code shows minimal relevant solicitation volume. The code nominally names a specific antineoplastic agent, but the recent opportunities tagged to it—an Illinois Department of Public Health pharmaceutical warehouse award and a Seminole County, Florida naloxone procurement—involve antibiotics, opioid antagonists, and drug deactivation systems rather than mitoguazone itself. This mismatch suggests either inconsistent coding by issuing bodies or a data-tagging error; the code shows little evidence of active market demand for the product named.
The two recent records span different issuing bodies and geographies but do not reflect sustained procurement under this Commodity code. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride with an initial 12-month term and two renewal options (notice number 26482DPHPREPDB53392, completed August 28, 2026). Seminole County, Florida issued an IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023 (IFB60459723LAS). Neither opportunity aligns with mitoguazone procurement. State and local buyers pursuing this Commodity code should verify code alignment with procurement staff or clarify whether opportunities are being misclassified at the point of posting.
Quick answers
What is UNSPSC 51111753?
UNSPSC 51111753 is Mitoguazone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51111753?
UNSPSC 51111753 maps to 1 NIGP code, 26908 Anti-Infective Agents.
On GovTribe
See everything under UNSPSC 51111753
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code